omniture
logo
Search
和其瑞医药（南京）有限公司 Heqirui Pharmaceutical (Nanjing) Co. LTD
Media Room

Latest News

rss

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

HMI-115 has demonstrated statistically significant improvement in endometriosis pain The mean dysm...

2024-10-24 08:08 3719
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia

SHANGHAI, Jan. 14, 2024 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical-stage innovative...

2024-01-15 08:08 1730

Hope Medicine Announces US FDA Clearance for Phase II Clinical Trial of A First-in-class Monoclonal Antibody, HMI-115, in Androgen Alopecia

SHANGHAI, Jan. 25, 2022 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical stage innovative...

2022-01-26 08:00 1865

Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical stage innovative...

2021-08-30 08:00 4975
Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer

Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation

SHANGHAI, May 6, 2021 /PRNewswire/ -- Recently, the global innovative drug R&D company Hope Medicin...

2021-05-06 08:00 6205

Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed') is a global innovative bioph...

2020-12-14 09:00 5513
Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development